Enumera Molecular
Ann Arbor, US · Founded 2022 · Delaware corporation · 16 employees on LinkedIn · 1 known investors
Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories. It targets clinical labs performing molecular diagnostics.
Founders & leadership
Enumera Molecular was founded in 2022 by Matthew Cooper.
MC
Matthew CooperCEO & Co-founder
EH
Elaine HeronNamed on SEC filing
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$31M disclosed across 2 rounds · 2022–2026
▶$12.3MraisedJul 2026 · 12 investors · Other Health CareRule 506(b)
▶$12.3MraisedJul 2026 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew CooperExecutive Officer, Director
- Dan KidleDirector
- Elaine HeronDirector
- Sundaresh BrahmasandraDirector
- Offering amount
- $17.4M
- Amount sold
- $12.3M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$18.7MraisedAug 2022 · 5 investors · Other Health CareRule 506(b)
▶$18.7MraisedAug 2022 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew CooperExecutive Officer, Director
- Offering amount
- $19M
- Amount sold
- $18.7M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
IDbyDNA4 shared keywordsScalable, high throughput DNA sequencing platforms.
Genomenon3 shared keywordsGenomenon uses AI to read biomedical literature and expert scientists to curate variant- and patient-level genomic evidence, delivering regulatory-grade real-world evidence. Its products, including Mastermind and CKB, serve drug development teams and clinical genetic testing labs for variant interpretation and drug program decisions.
Invitae3 shared keywordsInvitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.
Companies competing with Enumera Molecular for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Enumera Molecular do?
- Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories. It targets clinical labs performing molecular diagnostics.
- Who founded Enumera Molecular?
- Enumera Molecular was founded by Matthew Cooper in 2022.
- Who are Enumera Molecular's investors?
- Enumera Molecular's investors include Arboretum Ventures.
- How much funding has Enumera Molecular raised?
- Enumera Molecular has disclosed $31M raised across 2 rounds.
- Where is Enumera Molecular headquartered?
- Enumera Molecular is headquartered in Ann Arbor, US.